Their extensive work led to the development of GHRH agonists and antagonists, which have shown therapeutic potential in a wide range of fields, including cardiovascular diseases, diabetes and metabolic disorders, oncology, neurodegenerative diseases, and regenerative medicine. The gene discussed is GHRH; the disease is neurodegenerative disease.